Capital Advisory Group Advisory Services, LLC Eli Lilly & CO Transaction History

Capital Advisory Group Advisory Services, LLC

$250 Million
Q3 2024

A detailed history of Capital Advisory Group Advisory Services, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Capital Advisory Group Advisory Services, LLC holds 3,552 shares of LLY stock, worth $2.73 Million. This represents 1.26% of its overall portfolio holdings.

Number of Shares

3,552

Previous 3,552 -0.0%

Holding current value

$2.73 Million

Previous $3.22 Million 2.15%

% of portfolio

1.26%

Previous 1.38%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 22, 2024	SELL	$724.87 - $909.04 $5,798 - $7,272	-8 Reduced 0.22%	3,552 $3.22 Million
Q1 2024 Apr 18, 2024	BUY	$592.2 - $792.28 $88,830 - $118,842	150 Added 4.4%	3,560 $2.77 Million
Q4 2023 Jan 09, 2024	SELL	$525.19 - $619.13 $35,187 - $41,481	-67 Reduced 1.93%	3,410 $1.99 Million
Q3 2023 Oct 18, 2023	BUY	$434.7 - $599.3 $1.51 Million - $2.08 Million	3,477 New	3,477 $1.87 Million
Q1 2023 Apr 19, 2023	SELL	$310.63 - $364.82 $2,795 - $3,283	-9 Reduced 0.24%	3,667 $1.26 Million
Q4 2022 Feb 14, 2023	SELL	$321.55 - $374.67 $59,808 - $69,688	-186 Reduced 4.82%	3,676 $1.34 Million
Q3 2022 Nov 07, 2022	SELL	$296.48 - $337.87 $23,125 - $26,353	-78 Reduced 1.98%	3,862 $1.25 Million
Q2 2022 Aug 12, 2022	SELL	$278.73 - $327.27 $3,066 - $3,599	-11 Reduced 0.28%	3,940 $1.13 Million
Q1 2022 Apr 29, 2022	BUY	$234.69 - $291.66 $15,254 - $18,957	65 Added 1.67%	3,951 $1.13 Million
Q4 2021 Feb 15, 2022	BUY	$224.85 - $279.04 $22,934 - $28,462	102 Added 2.7%	3,886 $1.07 Million
Q3 2021 Nov 12, 2021	SELL	$221.6 - $272.71 $128,306 - $157,899	-579 Reduced 13.27%	3,784 $874,000
Q2 2021 Nov 12, 2021	BUY	$180.55 - $233.54 $24,193 - $31,294	134 Added 3.17%	4,363 $1 Million
Q1 2021 May 14, 2021	SELL	$164.32 - $212.72 $11,502 - $14,890	-70 Reduced 1.63%	4,229 $790,000
Q4 2020 Feb 18, 2021	BUY	$130.46 - $172.63 $231,696 - $306,590	1,776 Added 70.39%	4,299 $726,000
Q3 2020 Nov 16, 2020	BUY	$146.22 - $169.13 $144,465 - $167,100	988 Added 64.36%	2,523 $373,000
Q1 2020 May 18, 2020	SELL	$119.05 - $147.35 $23,810 - $29,470	-200 Reduced 11.53%	1,535 $214,000
Q1 2019 May 28, 2020	SELL	$111.31 - $131.02 $44,524 - $52,408	-400 Reduced 18.74%	1,735 $225,000
Q4 2018 May 28, 2020	SELL	$105.9 - $118.64 $32,299 - $36,185	-305 Reduced 12.5%	2,135 $246,000
Q3 2018 May 28, 2020	SELL	$85.86 - $107.31 $38,637 - $48,289	-450 Reduced 15.57%	2,440 $258,000
Q2 2018 May 28, 2020	SELL	$75.7 - $86.88 $3,785 - $4,344	-50 Reduced 1.7%	2,890 $248,000
Q1 2018 May 28, 2020	BUY	$74.21 - $87.6 $218,177 - $257,543	2,940 New	2,940 $225,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $730B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Advisory Group Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Advisory Group Advisory Services, LLC with notifications on news.

Account

Capital Advisory Group Advisory Services, LLC Eli Lilly & CO Transaction History